Case Report Volume 16 Issue 1
Received: January 15, 2026 | Published: February 16, 2026
Citation: Cuevas P, Angulo J, López-Gutiérrez JC. New topical treatment of infantile hemangioma. MOJ Clin Med Case Rep. 2026;16(1):12-13. DOI: 10.15406/mojcr.2026.16.00489
Infantile haemangioma is a benign angiogenesis-dependent tumour. We present here the efficacy of topical Dobesilate, a specific inhibitor of angiogenesis-dependent diseases, to treat an infantile eyelid haemangioma.
Keywords: infantile haemangioma, dobesilate, fibroblast growth factor, vascular endothelial growth factor
©2026 Cuevas, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.